T2 Biosystems Inc (TTOO)
0.50
+0.07
(+17.43%)
USD |
NASDAQ |
Nov 22, 14:42
T2 Biosystems Total Assets (Quarterly): 18.08M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 18.08M |
| June 30, 2024 | 21.72M |
| March 31, 2024 | 24.76M |
| December 31, 2023 | 34.80M |
| September 30, 2023 | 43.28M |
| June 30, 2023 | 37.13M |
| March 31, 2023 | 32.73M |
| December 31, 2022 | 34.33M |
| September 30, 2022 | 43.95M |
| June 30, 2022 | 39.60M |
| March 31, 2022 | 49.04M |
| December 31, 2021 | 60.54M |
| September 30, 2021 | 70.04M |
| June 30, 2021 | 78.90M |
| March 31, 2021 | 70.05M |
| December 31, 2020 | 79.08M |
| September 30, 2020 | 77.63M |
| June 30, 2020 | 53.71M |
| March 31, 2020 | 51.35M |
| December 31, 2019 | 28.49M |
| September 30, 2019 | 34.25M |
| June 30, 2019 | 45.17M |
| Date | Value |
|---|---|
| March 31, 2019 | 55.56M |
| December 31, 2018 | 64.31M |
| September 30, 2018 | 75.90M |
| June 30, 2018 | 84.21M |
| March 31, 2018 | 42.12M |
| December 31, 2017 | 54.86M |
| September 30, 2017 | 69.68M |
| June 30, 2017 | 63.78M |
| March 31, 2017 | 75.66M |
| December 31, 2016 | 89.57M |
| September 30, 2016 | 92.00M |
| June 30, 2016 | 65.91M |
| March 31, 2016 | 74.94M |
| December 31, 2015 | 86.82M |
| September 30, 2015 | 53.12M |
| June 30, 2015 | 63.71M |
| March 31, 2015 | 72.77M |
| December 31, 2014 | 79.13M |
| September 30, 2014 | 78.87M |
| June 30, 2014 | 20.05M |
| March 31, 2014 | 32.46M |
| December 31, 2013 | 31.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.08M
Minimum
Sep 2024
79.08M
Maximum
Dec 2020
47.46M
Average
43.62M
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp | 38.08B |
| Cardinal Health Inc | 43.06B |
| Perspective Therapeutics Inc | 391.15M |
| Electromed Inc | 48.92M |
| Xtant Medical Holdings Inc | 98.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.79M |
| Shareholders Equity (Quarterly) | -11.71M |
| Debt to Equity Ratio | -1.018 |
| Current Ratio | 0.4005 |
| Net Debt Paydown Yield | 20.92% |